AnGes

AnGes is a biopharmaceutical company specializing in R&D and practical application of genetic medicine. It provides the HGF plasmid gene therapy for the treatment of critical limb ischemia, an impairment of blood circulation in the leg. Additionally, the company develops a nucleic acid medicine that suppresses inflammation for diseases including low back pain.